Breaking News
Get 40% Off 0
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas tool Copy Portfolios
Close

Biora Therapeutics Inc (BIOR)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Biora Therapeutics's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.737 +0.022    +3.12%
16/05 - Closed. Currency in USD ( Disclaimer )
After Hours
0.740
+0.003
+0.407%
0:57:09 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 300,162
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.683 - 0.747
Biora Therapeutics 0.737 +0.022 +3.12%

Biora Therapeutics Inc Company Profile

 
Get an in-depth profile of Biora Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

58

Equity Type

ORD

Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.

Contact Information

Address 4330 La Jolla Village Drive Suite 300
San Diego, 92122
United States
Phone 833 727 2841
Fax -

Top Executives

Name Age Since Title
Lynne M. Powell 56 2019 Independent Director
Bruce E. Sands - 2021 Chairman of Inflammatory Bowel Disease Clinical Advisory Board
Satish Rao - - Chair of Clinical Advisory Board-SIBO/Functional Bowel Disorders
Anthony J. Lembo - - Member of Clinical Advisory Board SIBO & Functional Bowel Disorders
Mark Pimentel - - Member of Clinical Advisory Board - SIBO & Functional Bowel Disorders
Brian Gordon Feagan - - Member of Inflammatory Bowel Disease Clinical Advisory Board
Jeffrey Donald Alter 60 2019 Independent Chairman
Aditya P. Mohanty 56 2021 CEO & Director
Geert D’Haens - 2021 Member of Inflammatory Bowel Disease Clinical Advisory Board
William D. Chey - - Member of Clinical Advisory Board SIBO & Functional Bowel Disorders
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BIOR Comments

Write your thoughts about Biora Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email